Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 195

The DOI matches its Crossref record.

Effects of Flecainide in Patients With New SCN5A Mutation: Mutation-Specific Therapy for Long-QT Syndrome?

Open access
Benhorin, J., Taub, R., Goldmit, M., Kerem, B., Kass, R. S., Windman, I., Medina, A. · 2000 · Circulation

Abstract

Background —Mutations in the cardiac sodium channel gene ( SCN5A ) can cause one variant of the congenital long-QT syndrome. The effects of some of these mutations on the α-subunit channel properties can be blocked by type Ib antiarrhythmic drugs. Recently, we have described a new SCN5A mutation ( D1790G ) that affects the channel properties in a manner suggesting that sodium blockers of the Ib type will be ineffective in carriers of this mutation. Hence, the ECG effects of flecainide-acetate, a type Ic sodium blocker, were evaluated in carriers of this mutation. Methods and Results —Eight asymptomatic mutation carriers and 5 control subjects were studied. Intravenous lidocaine was tested first in only 2 mutation carriers and had no significant effect on any ECG parameter. Flecainide significantly shortened all heart rate–corrected repolarization duration parameters only in carriers and not in control subjects: QT c shortened by 9.5% (from 517±45 to 468±36 ms, P =0.011), and the S-offset to T-onset interval shortened by 64.7% (from 187±88 to 66±50 ms, P =0.0092). Flecainide also normalized the marked baseline repolarization dispersion in most mutation carriers. These effects among carriers were maintained during long-term (9 to 17 months) outpatient flecainide therapy with no adverse effects. Conclusions —This report is the first to describe SCN5A mutation carriers who significantly responded to flecainide therapy yet did not respond to lidocaine. These results have important implications for long-QT allele–specific therapeutic strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.101.14.1698

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 195

Metadata

Authors
Benhorin, J., Taub, R., Goldmit, M., Kerem, B., Kass, R. S., Windman, I., & Medina, A.
Venue
Circulation
Published
2000-04-11
Volume
101
Issue
14
Pages
1698-1706
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2085007473
Cited by
195
References
0
FWCI
10.81
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Flecainide in Patients With New SCN5A Mutation: Mutation-Specific Therapy for Long-QT Syndrome? https://app.cochat.ai/papers/10.1161/01.cir.101.14.1698
The paper
Benhorin, J., Taub, R., Goldmit, M., Kerem, B., Kass, R. S., Windman, I., & Medina, A. (2000). Effects of Flecainide in Patients With New SCN5A Mutation: Mutation-Specific Therapy for Long-QT Syndrome? Circulation. https://doi.org/10.1161/01.cir.101.14.1698

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.